Delivery Order SPE2DB24D2205-SPE2DB24FDXVW
Award Date
8/2/24
Potential Completion Date
8/5/24
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML to the Defense Logistics Agency (DLA), a defense agency. The $49,816.59 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 4, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,869.72 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 28, 2025 and was not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,420.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 29, 2025 with a completion date of May 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,483.24, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024 with a completion date of September 6, 2024. The contract is a delivery order with a firm fixed price pricing type. There is no set-aside designation mentioned. AmerisourceBergen holds significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML to the Defense Logistics Agency (DLA). The $6,966.24 firm-fixed-price delivery order has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,887.98 and an ultimate completion date of May 14, 2024. The contract is a Delivery Order under Firm Fixed Price terms. This award is not associated with a set-aside program. Amerisourcebergen holds a...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,587.71 firm fixed-price delivery order contract has a completion date of May 30, 2025 and was awarded on May 29, 2025 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Ozempic (0.25-0.5 mg/dose pen 3 mL) to the Defense Logistics Agency (DLA), a major defense agency. The $10,839.51 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. The contract is not set aside for any specific business type. As a key supplier of medical commodities to federal agencies, Amerisourcebergen holds several large...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $5,726.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024 with a completion date of September 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) valued at $5,959.91. The award is for the procurement of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product. The contract does not have a set-aside designation and has a period of performance through August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has multiple indefinite delivery contracts (IDCs) with various...